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ABSTRACT
Gene amplification contributes to a variety of bio-
logical phenomena, including malignant progres-
sion and drug resistance. However, details of the
molecular mechanisms remain to be determined.
Here, we have developed a gene amplification
system in yeast and mammalian cells that is based
on double rolling-circle replication (DRCR). Cre-lox
system is used to efficiently induce DRCR utilizing a
recombinational process coupled with replication.
This system shows distinctive features seen in
amplification of oncogenes and drug-resistance
genes: (i) intra- and extrachromosomal amplification,
(ii) intensive chromosome rearrangement and (iii)
scattered-type amplification resembling those seen
in cancer cells. This system can serve as a model for
amplification of oncogenes and drug-resistance
genes, and improve amplification systems used for
making pharmaceutical proteins inmammalian cells.
INTRODUCTION
Gene ampliﬁcation contributes to a variety of biological
phenomena, including malignant progression (1,2), drug
resistance (3,4), certain developmental processes (5),
adaptive mutation phenomena (6) and gene evolution
(7). However, details of the molecular mechanisms remain
to be determined (8–10). In cancer and drug-resistant cells,
breakage–fusion–bridge (BFB) cycles (11) form large
regular inverted repeats in the early stages of ampliﬁcation
and thereafter these repeats rapidly change into shorter
highly ampliﬁed units (8,10,12–14). However, it remains
largely unknown how complex end products can be rapidly
generated after BFB cycles. This rapid process has been
difﬁcult to analyze, since previous approaches to under-
stand ampliﬁcation mechanisms were based on the
structural analysis of end products. Therefore, we
decided to develop a designed ampliﬁcation system
in vivo to induce a rapid process and analyze the
products. Previously, we induced gene ampliﬁcation in
yeast, using recombinational processes induced by
chromosomal breaks designed to induce a rapid ampliﬁ-
cation process, double rolling-circle replication (DRCR)
(15). The ampliﬁcation products resemble two types of
product seen in mammalian cells, namely homogeneously
staining regions (HSR; intrachromosomal repetitive arrays
consisting mainly of inverted repeats) and double minutes
(DMs; acentric, autonomous, generally circular extrachro-
mosomal DNA with an inverted structure) (8–10).
In the present study, we used a distinct process, Cre-lox
recombination (16), to determine whether DRCR is cen-
trally involved in ampliﬁcation events in mammalian cells,
and to establish an in vivo ampliﬁcation system that work
well in mammalian cells. DRCR is a continuous process in
which two replication forks chase each other (Figure 1A)
and was conﬁrmed by Volkert and Broach for ampliﬁca-
tion of yeast 2 m plasmid (17). We ﬁrst conceived that
DRCR (15,17) can be induced by a recombinational
process coupled with replication (Figure 1B and C). The
ampliﬁcation system induced DRCR efﬁciently in yeast
and was shown to be a powerful tool for inducing gene
ampliﬁcation in Chinese hamster ovary (CHO) cells. The
features of this ampliﬁcation closely resembling those seen
in mammalian cells strongly suggest the involvement of
DRCR in ampliﬁcation of oncogenes and drug-resistance
genes.
MATERIALS AND METHODS
Yeast strains, plasmids and cell lines
Yeast strains, plasmids, cell lines and their construction are
described in Materials and Methods of the Supplementary
Data and Supplementary Figures S5–S7.
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Selection of yeast cells with gene ampliﬁcation
Induction of the Cre recombinase gene in yeast was carried
out as follows: cells were grown in SC (synthetic complete)
(18) liquid medium with 2% rafﬁnose, lacking Trp, Lys
and Ura, to mid-log phase. Then 0.1 volume of 20% gal-
actose was added and culture continued for 90min. The
cells were then harvested by centrifugation, washed twice
with sterile distilled water and plated at different dilutions
onto SC medium with 2% glucose. SC plates lacking Trp,
Lys, Ura and Leu were used for selection of cells with gene
ampliﬁcation and plates lacking Trp, Lys and Ura were
used for measurement of the number of viable cells. Cells
were grown at 25C. Colonies on the plates were counted
after 4 days of growth. A working protocol is described in
Materials and Methods of the Supplementary Data.
Pulsed-ﬁeld gel electrophoresis and Southern analysis
Cells were embedded in agarose plugs as per the instruc-
tion manual of the CHEF plug mold kit (Bio-Rad). The
gel-plugs were then treated with 5mg/ml proteinase K at
37C for 2 days and washed twice with TE buffer contain-
ing 1mM Pefabloc SC (Roche), twice with TE buffer
and once with 1 restriction enzyme buffer. Pulsed-
ﬁeld gel electrophoresis (PFGE) was performed with the
CHEF Mapper XA system (Bio-Rad) in 1% agarose gels
with 0.5 TBE buffer. The autoalgorithm mode of
the system was used with the size range of 150–800
(Figures 1F and 2C; Supplementary Figure S2A and B),
3–25 (Figures 1G and 2D; Supplementary Figures S1B,
S1D and S3A), 10–60 (Figures 1H and 2E). Southern
blotting was performed onto Hybond-N+ membrane
(GE Healthcare) according to Sambrook et al. (19)
Hybridization was performed with ﬂuorescein-labeled
probes, which were prepared with the Gene Images
random-prime labeling module (GE Healthcare), and
detected and quantiﬁed with a luminescent image
analyzer, LAS-1000plus (Fujiﬁlm).
Cell transfection and methotrexate selection
Flp-In CHO cells (Invitrogen) were transfected with the
Flp recombinase expression vector pOG44 (Invitrogen)
and subsequently transfected with the modiﬁed bacterial
artiﬁcial chromosome (BAC) clone by Targefect-BAC
(Targeting systems). After hygromycin B selection, cells
with the BAC were cloned. The BAC-CHO clones
were transfected with the Cre recombinase expression
vector pPGK-Cre-bpA. Methotrexate (MTX) selection
was carried out in 96-well plates. MTX-resistant cells
Figure 1. Recombinational process coupled with replication. (A) DRCR. Two replication forks chase each other. One replication fork can replicate a
template for the other fork and so ampliﬁcation proceeds. (B) Recombinational process coupled with replication. The gray and black lines indicate
the un-replicated and recently replicated regions at the time of recombination, respectively. If recombination occurs between loxP sites marked red
and blue (i), the replication template is switched and thereafter the replicated region is replicated again (ii). (C) DRCR induction. If both bidirec-
tional DNA replications undergo the processes as described in (B), DRCR can be induced. (D) Structure of the loxPs cassette, a model for the
production of the minichromosome, and the predicted structure of the 18 kb DM-type products. The SmaI sites (vertical lines), and the sizes (kb) of
fragments that hybridize with the leu2d probe are shown. The gray arrows below indicate an inverted structure. (E) Frequency of Leu+ colony
formation. The colonies were counted as described in Materials and Methods of Supplementary Data. CRE: Cre-induced condition; cre: negative
control. (F) Southern analysis of a representative sample of survivors with the leu2d probe. PFGE and Southern analysis were performed as described
in Materials and Methods of Supplementary Data. The colony numbers are indicated above. M: Saccharomyces cerevisiae marker; P: the parental
strain (LS20); NS: non-selective conditions. (G) Southern analysis of SmaI-digested DNA of the samples from (F) with the leu2d probe. (H) SYBR
Green I staining and Southern analysis of the samples from colony #03 by PFGE for lower range.
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Figure 2. Cre-lox dependent DRCR ampliﬁcation in yeast. (A) Structure of the m2s–loxPs cassette and a model for DRCR ampliﬁcation. The sizes
(kb) of the three regions in the structure are indicated below. A possible model for termination of the DRCR process is provided in Supplementary
Figure S2D. (B) Frequency of Leu+ colony formation. CRE: Cre-induced condition; cre: negative control. (C) Southern analysis of a representative
sample of m2s–loxPs survivors with the leu2d probe. The lanes marked in red and green indicate HSR- and DM-type products, respectively.
Supplementary information, including the description of the lanes marked in gray, is provided in Supplementary Texts. M: S. cerevisiae marker;
P: the parental strain (LS20); NS: non-selective conditions. (D) Southern analysis of SmaI-digested DNA of the samples from (C) with the leu2d
probe. (E) Southern analysis of a representative sample with DM-type products by PFGE for lower range. (F) The predicted structure of the 18, 29
and 40 kb DM-type products. The SmaI sites (vertical lines) and the sizes (kb) of fragments that hybridize with the leu2d probe are shown. The gray
arrows below indicate an inverted structure. (G) Schematic representation of the expected structure derived through the DRCR process and
SmaI-restriction maps of the representative HSR-type structure. Inverted repeats that can engage in DRCR-dependent inversion are marked with
red backgrounds. The gray arrows indicate a palindromic structure.
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were screened for secreted alkaline phosphatase (SEAP),
cloned and analyzed by ﬂuorescence in situ hybridization
(FISH). Details of these procedures and a working
protocol are described in Materials and Methods of the
Supplementary Data.
Interphase and metaphase FISH
The samples were ﬁxed, denatured, hybridized and ﬂuor-
escence detected as described previously (20). For metaphase
FISH, cells were treated with colcemid and Chromosome
Resolution Additive (Genial Genetic Solutions, Chester,
UK) for 2 and 1.5 hours before cell harvest, respectively,
and were subjected to hypotonic treatment before ﬁxation.
The modiﬁed BAC construct and pSV2-dhfr plasmid were
biotinylated for use as probes, and visualized by the
FITC-conjugated avidin and biotinylated antiavidin
antibody combination system (Vector). Details of these
techniques are described in Materials and Methods of
Supplementary Data.
RESULTS
Recombinational process coupled with replication
We ﬁrst predicted that, if recombination occurs between
un-replicated and recently replicated regions during repli-
cation (Figure 1B), the replication fork will make an
additional copy of the replicated region. To demonstrate
this process, we constructed the strain loxPs in which
the right terminus region of chromosome VI was
modiﬁed (Figure 1D, top). An autonomously replicating
sequence (ARS) is naturally located in the subtelomeric
region (21). The ampliﬁcation marker, leu2d (black
arrows in Figure 1D), has slight transcriptional activity
and can complement leucine auxotrophy only if ampliﬁed.
If the recombinational process occurs, a minichromosome
should be produced (Figure 1D, bottom) whose copy num-
ber will increase under selection. To induce Cre-lox recom-
bination, a galactose-inducible Cre expression vector
(CRE) or a control vector (cre) was used. We induced
Cre expression in galactose medium and then plated these
strains on glucose plates lacking leucine to select Leu+
survivors (those with ampliﬁcation). The Cre induction
caused a 7000-fold increase in the frequency of survivors
(Figure 1E). Chromosomal and SmaI-digested DNA from
Leu+ survivors was separated by PFGE and hybridized
with the leu2d gene as the probe. As expected, a linear
minichromosome of 18 kb in length (Figure 1F and
H), yielding a 6.3 kb leu2d SmaI fragment (Figure 1G),
was produced in a Cre-dependent manner. The signal in-
tensity indicated approximately 27 copies of minichromo-
some (clone #03, Supplementary Figure S2A). The
frequent appearance of this minichromosome demon-
strates that Cre-lox recombination can efﬁciently cause
the recombinational process coupled with replication.
Cre-lox-dependent gene ampliﬁcation system in yeast
The above results imply that two recombinational
processes could induce DRCR (Figure 1C). To explore
this further, we used two different types of lox sequence,
the wild-type loxP (lox for short) and a mutant-type loxm2
(m2 for short). Cre recombination occurs between identi-
cal sites (lox–lox or m2–m2) but not between different sites
(lox–m2). Using these cis-elements (lox and m2) and the
leu2d gene, we constructed an ampliﬁcation cassette
(Figure 2A). A natural ARS consensus sequence that ex-
hibits ARS activity (21) is located in the region between
the lox pair and m2 pair. Using the strain designated
m2s–loxPs, we repeated the experiment as described
above.
The Cre induction caused a >7000-fold increase in the
frequency of survivors (Figure 2B) and 12% of the Cre-
induced cells survived. Structural analysis of the chromo-
somes revealed the generation of two distinct leu2d
ampliﬁcation products resembling HSR and DMs in
Cre-dependent Leu+ clones (Figure 2C and D). Detailed
analysis of DM-type products indicated linear mini-
chromosomes of at least three sizes (18, 29 and 40 kb;
Figure 2E and F), whose formation can be explained by
three types of the recombinational processes (Supplementary
Figure S1). Interestingly, even under cre condi-
tions (clones #15–22 in Figure 2C), homology-based re-
combination can produce 29 kb minichromosomes. The
signal intensity of these DMs products indicated 15–30
mini chromosome copies (Supplementary Figure S2A).
The HSR-type products generated a quite different
pattern; the original chromosome VI band containing
the m2s-loxs constructs (290 kb) disappeared and very
dense DNA spots appeared above the separation limit
and at the well position, indicating that extensive ampliﬁ-
cation of leu2d results in elongation of chromosome VI.
The ampliﬁcation occurs within the chromosome, since a
chromosome VI-speciﬁc probe, RET2, hybridized to the
same chromosomal fragments as the leu2d probe
(Supplementary Figure S2B). The signal intensity of
leu2d from the HSR-type products indicated the presence
of 90–140 copies of the leu2d gene (Supplementary
Figure S2A), corresponding to a 3.6–5.6-fold increase in
the length of the original (275 kb) chromosome VI
(Supplementary Figure S2C). Thus, our yeast system
generated HSR- or DM-type products at high frequency
(>10%).
We previously found that sequences ﬂanked by inverted
repeats, which are formed by DRCR ampliﬁcation, were
subject to frequent inversion (15). We call this phenom-
enon DRCR-dependent inversion, which can explain the
production of 17 kb SmaI fragments in addition to the
10.9 and 11.1 kb SmaI fragments that DRCR originally
ampliﬁes (Figure 2G). This type of inversion could also
explain the results using other restriction enzymes (EcoRI,
HindIII, PstI and XbaI) (Supplementary Figure S3).
Gene ampliﬁcation system in CHO cells induced by Cre-
lox recombination
Next, we attempted to induce gene ampliﬁcation in CHO
cells in this way. We constructed an ampliﬁcation cassette
on a rat genomic BAC (Figure 3A) and integrated it into a
speciﬁc site on a CHO cell chromosome using the
Flp-FRT (Flp recombination target site) system (16).
The resulting structure is equivalent to that in the yeast
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Figure 3. Gene ampliﬁcation in CHO cells induced by Cre recombination. See details in the text and Supplementary Materials and Methods. (A)
Structure of the modiﬁed BAC and construction of the CHO strain for gene ampliﬁcation. The sizes (kb) of the three regions in the structure are
indicated below. (B–K) Metaphase FISH analysis with FITC-labeled probes (green). The CHO DR1000L-4N (CHO-4N) strain (B) that contains
approximately 170 copies of DHFR was probed with a pSV2-dhfr plasmid. The BAC-CHO strain (C; 1B12) without Cre induction and MTX
selection and MTX-resistant clones (D–K) were probed with the BAC in (A). DNA is counterstained with DAPI (blue). The scale bars represent
10 mm. These ampliﬁed products would be derived from the integrated BAC construct because the BAC probe could not detect the original DHFR
locus (Supplementary Texts). (L) A model for the HSR ampliﬁcation and DMs production by Cre recombination coupled with replication. See
details in the text.
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system. An ampliﬁcation marker, a mouse dihydrofolate
reductase (DHFR) gene, provides MTX resistance when
ampliﬁed.
This CHO-derived cell line, designated BAC-CHO, was
transiently transfected with a Cre expression vector,
pPGK-Cre and grown under selection for resistance to
MTX. Cre-induced cells showed an increased expression
of a reporter gene located in the BAC construct (Materials
and Methods in Supplementary Data). The
MTX-resistant cells were then screened and cloned. Two
foci derived from the BAC-CHO strain without
Cre-induction showed very slow growth in the concentra-
tion of MTX, consequently resulting in growth arrest. To
determine whether the MTX-resistant clones had
undergone gene ampliﬁcation, we used FISH on meta-
phase spreads with the BAC construct probe. Controls
for the FISH detection of chromosomal ampliﬁcation
were CHO DR1000L-4N (CHO-4N) cells that contain ap-
proximately 170 copies of DHFR (Figure 3B); the
BAC-CHO line (1B12) tested before Cre induction acted
as a control for cells with a single BAC copy (Figure 3C).
In the samples of MTX-resistant clones analyzed
(Supplementary Table S1); three characteristic types of
product were observed. The ﬁrst type of products
(Figure 3D–G) exhibited localization of ﬂuorescent
signals similar to the CHO-4N strain (Figure 3C). These
cells appear to have ampliﬁed a region within the chromo-
some, indicating HSR ampliﬁcation. Some of the
HSR-type cells showed approximately a 20–50-fold
increase in ﬂuorescence intensity (Supplementary
Figure S4). Detailed analysis of some of the HSR-type
clones showed that the ampliﬁed regions contained the
BAC sequence but that this was associated with chromo-
some rearrangements (Watanabe T., Horiuchi T., unpub-
lished data). The second type of products (Figure 3H–J)
were characterized by ﬂuorescent signals dispersed over
the nuclei, and are presumed to represent extrachromo-
somal products, DMs. The third type of products
(Figure 3K) yielded scattered signals on chromosomes
similar to those seen in cancer cells. The formation of
HSR/DM-type products can be explained by Cre recom-
bination coupled with replication in two alternative ways,
by trans- or cis-recombination, which can induce either
DRCR or convergent replication, respectively (Figure
3L). The scattered-type ampliﬁcation may be generated
by reintegration of DM-type products into ectopic
chromosomes through interspersed repetitive elements.
DISCUSSION
The data described above indicate that the Cre-lox system
can amplify any selectable genes via DRCR in both yeast
and mammalian cells and further show scattered-type
products resembling those seen in caner cells. Previously,
a distinct recombinational process induced by chromo-
somal breaks was designed to induce DRCR and conse-
quently produced HSR/DM-type products in yeast (15).
These ﬁndings strongly suggest that DRCR is directly
involved in the ampliﬁcation events. In gene ampliﬁca-
tion in mammalian cells, BFB cycles would form
megabase-sized inverted repeats, which may induce
DRCR if homology-based recombination is coupled
with DNA replication. Recently, a similar process, repli-
cation template exchange, was reported to lead to acentric
or dicentric chromosome formation in yeast, indicating an
important contribution to genome instability (22,23). We
propose that such processes can occur in cultured cells and
tumor cells through genome instability associated with
deregulated replication (24,25). We have recently found
that two pairs of inverted repeats (3 kb) induced HSR/
DM-type products in yeast (Watanabe T., Horiuchi T.,
unpublished data), similarly to the Cre-lox system,
strongly suggesting DRCR can be spontaneously
induced by homology-based recombination. This involve-
ment of DRCR can explain a recent data that HSR was
lengthened more rapidly than expected from BFB cycle
model (26).
Our Cre-lox system can induce tissue-speciﬁc ampliﬁca-
tion of gene of interest, and therefore may allow a direct
approach to examine which genetic elements contribute to
oncogenesis or malignant potential in each tissue when
ampliﬁed. In addition, our CHO system showed
scattered-type ampliﬁcation products resembling those
seen in cancer cells, although in non-cancerous cell line.
Thus, the system in this study should serve as a useful
model for ampliﬁcation of oncogenes and drug-resistance
genes, and contribute to a better understanding of
oncogene ampliﬁcation and development of anticancer
strategies in future.
DRCR-dependent inversion is an interesting phenom-
enon, but the mechanism remains unknown. DRCR is
expected to form an unstable structure, a palindromic
structure. We propose that DRCR-dependent inversion
may disrupt the palindromic structure and substantially
stabilize the highly repetitive array. In our yeast system,
the inversions were frequently found, and the ﬁnal ampli-
ﬁcation level of leu2d (approximately 100 copies) far
exceeded that required for complementation (10–20
copies). Our CHO system showed an adequate magnitude
of ampliﬁcation, given that approximately a 20- to 50-fold
increase in ﬂuorescence intensity and chromosome re-
arrangements was found in the HSR-type products.
Furthermore, DRCR may be associated with deletions,
as well as inversions, since intensive rearrangement was
found in the ampliﬁed region of our CHO system. We
have recently shown that DRCR process activates inver-
sion or deletion/duplication using yeast 2-micron plasmid
and an ampliﬁcation system on a yeast chromosome (27).
This DRCR-dependent rearrangement may occur via
interspersed repetitive elements abundant in higher eu-
karyotic genomes, and serve as a good model for the sec-
ondary rearrangements in mammalian gene ampliﬁcation.
Gene ampliﬁcation is a widely used strategy for making
pharmaceutical proteins in mammalian cells (28). Since
our DRCR system shares features with gene ampliﬁcation
seen in CHO cells, we speculate that our system could
produce as much recombinant protein as a conventional
CHO cell expression system. Our DRCR system can
shorten the process of developing high-producing cell
lines with gene ampliﬁcation, and be applied to a system-
atic production of large variety of proteins or tissue-/
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time-speciﬁc ampliﬁcation. Improvement of the CHO
system to form longer inverted repeats that facilitate
DRCR-dependent inversion may allow a much higher
level of ampliﬁcation. Our system may be applied to
other systems, such as an artiﬁcial chromosome system
(28) and transgenic animals and plants for protein pro-
duction (29). Finally, a unique feature of this study
is the explosive nature of the HSR-type ampliﬁcation.
If the ampliﬁcation yields multiple mutations, this
type of process may contribute importantly to gene
evolution.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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